España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
NRX Pharmaceuticals
NRXP
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.28
-0.17
-6.94%
At close: -
$2.25
-0.03
-1.32%
After Hours: 4:57 PM EDT
Get Report
Comment
NRX Pharmaceuticals (NRXP) Forecast
News
Earnings
NRX Pharmaceuticals (NRXP) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for NRX Pharmaceuticals (NASDAQ:NRXP) Stock
NRX Pharmaceuticals Stock (NASDAQ: NRXP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, January 28, 2025
What's Going On With NRX Pharmaceuticals Stock Tuesday?
Dylan Berman
D. Boral Capital Maintains Buy on NRX Pharmac...
Benzinga Newsdesk
NRx Pharmaceuticals shares are trading higher...
Benzinga Newsdesk
NRx Pharmaceuticals And Hope Therapeutics Sig...
Benzinga Newsdesk
Tuesday, January 21, 2025
NRx Pharmaceuticals Regains Compliance With N...
Benzinga Newsdesk
Monday, January 13, 2025
NRx Pharmaceuticals Has Filed An Application ...
Benzinga Newsdesk
Monday, January 06, 2025
NRX Pharmaceuticals shares are trading higher...
Benzinga Newsdesk
D. Boral Capital Maintains Buy on NRX Pharmac...
Benzinga Newsdesk
HOPE Therapeutics And NRx Pharmaceuticals Ann...
Benzinga Newsdesk
HOPE Therapeutics And NRx Pharmaceuticals Ann...
Benzinga Newsdesk
Friday, January 03, 2025
NRX Pharmaceuticals shares are trading higher...
Benzinga Newsdesk
NRx Pharmaceuticals Subsidiary, HOPE Therapeu...
Benzinga Newsdesk
Thursday, January 02, 2025
What's Going On With NRX Pharmaceuticals Stock Thursday?
Dylan Berman
NRX Pharmaceuticals shares are trading higher...
Benzinga Newsdesk
D. Boral Capital Maintains Buy on NRX Pharmac...
Benzinga Newsdesk
Hope Therapeutics And NRx Pharmaceuticals Pla...
Benzinga Newsdesk
Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, December 31, 2024
D. Boral Capital Maintains Buy on NRX Pharmac...
Benzinga Newsdesk
Monday, December 30, 2024
NRx Pharmaceuticals Files Initial Section of ...
Benzinga Newsdesk
Monday, December 02, 2024
Ascendiant Capital Maintains Buy on NRX Pharm...
Benzinga Newsdesk
Monday, November 25, 2024
HC Wainwright & Co. Reiterates Buy on NRX Pha...
Benzinga Newsdesk
NRx Pharmaceuticals Publishes Study In Americ...
Benzinga Newsdesk
Monday, November 18, 2024
NRx Pharmaceuticals Appoints Michael Abrams A...
Benzinga Newsdesk
Friday, November 15, 2024
D. Boral Capital Maintains Buy on NRX Pharmac...
Benzinga Newsdesk
Wednesday, November 13, 2024
NRx Pharmaceuticals Reschedules Conference Ca...
Benzinga Newsdesk
Wednesday, October 30, 2024
EF Hutton Maintains Buy on NRX Pharmaceutical...
Benzinga Newsdesk
HOPE Therapeutics And A Wholly-owned Subsidia...
Benzinga Newsdesk
Monday, October 21, 2024
EF Hutton Initiates Coverage On NRX Pharmaceu...
Benzinga Newsdesk
Thursday, October 03, 2024
Hope Therapeutics And A Wholly-owned Subsidia...
Benzinga Newsdesk
Monday, September 30, 2024
NRx Pharmaceuticals Hits Key Milestone with 1...
Benzinga Newsdesk
Thursday, September 12, 2024
Ascendiant Capital Maintains Buy on NRX Pharm...
Benzinga Newsdesk
Monday, August 26, 2024
HOPE Therapeutics Secures $30M For Ketamine Clinic Expansion, Projects $100M Revenue By 2025
Rolando García
NRX Pharma's HOPE Therapeutics Secures Debt F...
Benzinga Newsdesk
Wednesday, August 14, 2024
NRX Pharmaceuticals Q2 2024 GAAP EPS $(0.75) ...
Benzinga Newsdesk
Tuesday, August 13, 2024
NRx Pharmaceuticals Has Obtained Up To Approx...
Benzinga Newsdesk
Monday, August 05, 2024
HC Wainwright & Co. Maintains Buy on NRX Phar...
Benzinga Newsdesk
Monday, July 29, 2024
NRx Pharmaceuticals Announce Alignment With F...
Benzinga Newsdesk
NRx Pharmaceuticals Announced The Issuance Of...
Benzinga Newsdesk
Monday, July 01, 2024
NRx Pharmaceuticals Outlines Potential Paths ...
Benzinga Newsdesk
Friday, June 28, 2024
NRx Pharmaceuticals To Proceed With Two New D...
Benzinga Newsdesk
Monday, June 10, 2024
NRx Pharmaceuticals Publishes Shareholder Upd...
Benzinga Newsdesk
Friday, June 07, 2024
Ascendiant Capital Maintains Buy on NRX Pharm...
Benzinga Newsdesk
Tuesday, May 28, 2024
NRx Pharmaceuticals Presents Landmark Trial O...
Benzinga Newsdesk
Thursday, May 16, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Tuesday, May 14, 2024
NRX Pharmaceuticals Q1 EPS $(0.74) Misses $(0...
Benzinga Newsdesk
Monday, May 06, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
NRx Pharmaceuticals shares are trading higher...
Benzinga Newsdesk
NRx Pharmaceuticals Announces Final Clinical ...
Benzinga Newsdesk
Wednesday, May 01, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, April 30, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
